These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 35963476)
1. Differences across sexes on head-twitch behavior and 5-HT Jaster AM; Younkin J; Cuddy T; de la Fuente Revenga M; Poklis JL; Dozmorov MG; González-Maeso J Neurosci Lett; 2022 Sep; 788():136836. PubMed ID: 35963476 [TBL] [Abstract][Full Text] [Related]
2. Effects of the 5-HT Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648 [TBL] [Abstract][Full Text] [Related]
3. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876 [TBL] [Abstract][Full Text] [Related]
4. Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice. Vohra HZ; Saunders JM; Jaster AM; de la Fuente Revenga M; Jimenez J; Fernández-Teruel A; Wolstenholme JT; Beardsley PM; González-Maeso J Psychopharmacology (Berl); 2022 Jun; 239(6):1649-1664. PubMed ID: 34345931 [TBL] [Abstract][Full Text] [Related]
5. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710 [TBL] [Abstract][Full Text] [Related]
6. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen. Canal CE; Olaghere da Silva UB; Gresch PJ; Watt EE; Sanders-Bush E; Airey DC Psychopharmacology (Berl); 2010 Apr; 209(2):163-74. PubMed ID: 20165943 [TBL] [Abstract][Full Text] [Related]
7. Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice. Takaba R; Ibi D; Yoshida K; Hosomi E; Kawase R; Kitagawa H; Goto H; Achiwa M; Mizutani K; Maeda K; González-Maeso J; Kitagaki S; Hiramatsu M Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3019-3035. PubMed ID: 37874338 [TBL] [Abstract][Full Text] [Related]
8. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice. Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706 [TBL] [Abstract][Full Text] [Related]
9. Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications. Shahar O; Botvinnik A; Esh-Zuntz N; Brownstien M; Wolf R; Lotan A; Wolf G; Lerer B; Lifschytz T Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430623 [TBL] [Abstract][Full Text] [Related]
10. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex. Schindler EA; Harvey JA; Aloyo VJ Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701 [TBL] [Abstract][Full Text] [Related]
11. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Halberstadt AL; Chatha M; Klein AK; Wallach J; Brandt SD Neuropharmacology; 2020 May; 167():107933. PubMed ID: 31917152 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD). Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337 [TBL] [Abstract][Full Text] [Related]
14. Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice. de la Fuente Revenga M; Shah UH; Nassehi N; Jaster AM; Hemanth P; Sierra S; Dukat M; González-Maeso J ACS Chem Neurosci; 2021 Mar; 12(5):831-844. PubMed ID: 33400504 [TBL] [Abstract][Full Text] [Related]
15. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. Marek GJ; Aghajanian GK J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Halberstadt AL; Geyer MA Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781 [TBL] [Abstract][Full Text] [Related]
17. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305 [TBL] [Abstract][Full Text] [Related]
18. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice. Fantegrossi WE; Gray BW; Bailey JM; Smith DA; Hansen M; Kristensen JL Psychopharmacology (Berl); 2015 Mar; 232(6):1039-47. PubMed ID: 25224567 [TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen. Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]